387 related articles for article (PubMed ID: 20495363)
1. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
[TBL] [Abstract][Full Text] [Related]
2. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
Pavlides S; Whitaker-Menezes D; Castello-Cros R; Flomenberg N; Witkiewicz AK; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2009 Dec; 8(23):3984-4001. PubMed ID: 19923890
[TBL] [Abstract][Full Text] [Related]
3. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
Migneco G; Whitaker-Menezes D; Chiavarina B; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Flomenberg N; Tsirigos A; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 Jun; 9(12):2412-22. PubMed ID: 20562527
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.
Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP
Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
Balliet RM; Capparelli C; Guido C; Pestell TG; Martinez-Outschoorn UE; Lin Z; Whitaker-Menezes D; Chiavarina B; Pestell RG; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2011 Dec; 10(23):4065-73. PubMed ID: 22129993
[TBL] [Abstract][Full Text] [Related]
8. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.
Pavlides S; Tsirigos A; Vera I; Flomenberg N; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 Jun; 9(11):2201-19. PubMed ID: 20519932
[TBL] [Abstract][Full Text] [Related]
9. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
Martinez-Outschoorn UE; Balliet RM; Rivadeneira DB; Chiavarina B; Pavlides S; Wang C; Whitaker-Menezes D; Daumer KM; Lin Z; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Knudsen ES; Sotgia F; Lisanti MP
Cell Cycle; 2010 Aug; 9(16):3256-76. PubMed ID: 20814239
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
12. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.
Capparelli C; Whitaker-Menezes D; Guido C; Balliet R; Pestell TG; Howell A; Sneddon S; Pestell RG; Martinez-Outschoorn U; Lisanti MP; Sotgia F
Cell Cycle; 2012 Jun; 11(12):2272-84. PubMed ID: 22684333
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
Sotgia F; Del Galdo F; Casimiro MC; Bonuccelli G; Mercier I; Whitaker-Menezes D; Daumer KM; Zhou J; Wang C; Katiyar S; Xu H; Bosco E; Quong AA; Aronow B; Witkiewicz AK; Minetti C; Frank PG; Jimenez SA; Knudsen ES; Pestell RG; Lisanti MP
Am J Pathol; 2009 Mar; 174(3):746-61. PubMed ID: 19234134
[TBL] [Abstract][Full Text] [Related]
14. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
15. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.
Martinez-Outschoorn UE; Pavlides S; Whitaker-Menezes D; Daumer KM; Milliman JN; Chiavarina B; Migneco G; Witkiewicz AK; Martinez-Cantarin MP; Flomenberg N; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2010 Jun; 9(12):2423-33. PubMed ID: 20562526
[TBL] [Abstract][Full Text] [Related]
16. Clinical and functional significance of loss of caveolin-1 expression in breast cancer-associated fibroblasts.
Simpkins SA; Hanby AM; Holliday DL; Speirs V
J Pathol; 2012 Aug; 227(4):490-8. PubMed ID: 22488553
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
[TBL] [Abstract][Full Text] [Related]
18. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.
Chiavarina B; Whitaker-Menezes D; Migneco G; Martinez-Outschoorn UE; Pavlides S; Howell A; Tanowitz HB; Casimiro MC; Wang C; Pestell RG; Grieshaber P; Caro J; Sotgia F; Lisanti MP
Cell Cycle; 2010 Sep; 9(17):3534-51. PubMed ID: 20864819
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling".
Pavlides S; Tsirigos A; Vera I; Flomenberg N; Frank PG; Casimiro MC; Wang C; Pestell RG; Martinez-Outschoorn UE; Howell A; Sotgia F; Lisanti MP
Aging (Albany NY); 2010 Apr; 2(4):185-99. PubMed ID: 20442453
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
